Loading
Onxeo Logo

Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or the “Company”), a clinical-stage biotechnology company specializing in the development of innovative drugs for the treatment of orphan diseases, in particular in oncology, today announces the Company has granted a global exclusive license of its product Validive® (clonidine mucoadhesive buccal tablet) developed for the treatment of severe oral mucositis induced by radiotherapy or chemotherapy in patients suffering from head and neck cancer to Monopar Therapeutics (Chicago, Illinois, USA), a biopharmaceutical company focused on developing innovative drug combinations to improve clinical outcomes in advanced cancer.

The world’s largest independent cancer research charity, Cancer Research UK, is placing a bet on a biopharma startup’s experimental cancer treatment. The organization has reached an agreement with Monopar Therapeutics to finance and coordinate preclinical development of an antibody that targets the cell surface protein uPAR.

An emerging biopharmaceutical company focused on developing orphan oncology compounds which was co-founded by Gates Cambridge Alumnus Chandler Robinson has joined forces with cancer research organisations in the UK to take an experimental antibody treatment into clinical trials with cancer patients.

Monopar Therapeutics LLC, an emerging biopharmaceutical company focused on developing orphan oncology compounds, has reached an agreement with Cancer Research UK and Cancer Research Technology (CRT) to take forward Monopar’s experimental antibody treatment HuATN-658 into clinical trials in cancer patients with advanced solid tumors. HuATN- 658 is an antibody that targets the cell surface protein uPAR, which is found in high levels in some of the most deadly cancers.

Monopar Therapeutics LLC, an emerging biopharmaceutical company focusing on developing orphan oncology compounds, announced that its co-founder and CEO, Chandler D. Robinson MD, MBA, MSc, received the British Council’s Education U.K. Alumni Entrepreneurial Award. The award recognizes outstanding achievements made by entrepreneurs who have leveraged their U.K. education in their subsequent successes. Dr. Robinson was selected due to his entrepreneurial activities which he burnished while he was a Gates Scholar at the University of Cambridge.